A R T I C L E S
Krishnamurthy et al.
r 2 1/2 ) (C/l)l n ) C n
(3)
x
x
Winnik and Mandolini have reviewed the literature for ring-
closing (macrocyclization) reactions in small-molecule systems
and concluded that Ceff and Meff are closely correlated for many
of these reactions.3,10
In many situations (and, in particular, in protein-ligand
binding), we are not concerned with the probability that the
two ends of the linker are an infinitesimal distance apart. Rather,
we require the probability that the two ends are a distance d
apart, where d is set by the system (Figures 1D,E and 3B). Lees
and co-workers derived eq 4 for this case, where Ceff(0) is Ceff
defined in eq 2.1 The parameter p arises because of the presence
of the protein: the ligand cannot occupy the same space as the
protein, and because it is excluded from this volume, its Ceff
increases (a so-called “excluded volume” effect). Lees and co-
workers proposed a value of 2 for this term; this value assumes
that the ligand has only a hemisphere of free access when
constrained by the protein (Figure 1E), as compared to a sphere
when it is free in solution.1
Figure 4. Model for the interaction of p-H2NSO2C6H4CONH(CH2CH2O)2-
+
CH2CH2NH3 (ArEG3NH3+) with HCA based on the deposited X-ray
3
Ceff(d) ) pCeff(0) exp -
d 2
(4)
crystallographic coordinates (PDB code 1CNX).21 The arylsulfonamide
ligand is rendered as a ball-and-stick model in CPK color scheme. HCA is
depicted as a light blue ribbon diagram, with the catalytically essential Zn2+
cofactor shown as a green sphere. Lys-133 of HCA II is represented as a
red ball-and-stick model. The distance (d) between the last glycol unit of
the ligand and the γ-CH2 group of Lys-133 (corresponding to the thiol in
the LysfCys HCA** mutant) is indicated by the dashed line.
2( r 2 1/2 2
)
(
)
We have defined multivalency as multiple interactions (often
of the same kind) between two different species.4,11 Theoretical
approaches to multivalency have assumed a stepwise pathway
for dissociation, in which the first step is intramolecular (Figure
1E). The value of the dissociation constant (2Kdintra*) for this
step has been a challenge to estimate theoretically.4 Without
an estimate for this parameter, we cannot predict multivalent
avidities from the component monovalent affinities (although
the work by Lees, Reinhoudt, and others represents a significant
advance toward this capability).1,6,7 The study presented here
clarifies and simplifies this problem, because we obtain empiri-
cal estimates for the dissociation constants for intramolecular
protein-ligand binding that are applicable to the thermo-
dynamics of the intramolecular step in multivalent binding
(Figure 1D,E).
We have previously argued that flexible oligomers should
not function effectively as linkers in multivalent ligands because
of the severe loss in conformational entropy of the linker (T∆S°
≈ RT ln 3 ≈ 0.7 kcal mol-1 per freely rotating single bond of
the linker) when it is bound at both ends.4,11,12 Flexible linkers
(e.g., oligo(ethylene glycol)) have, however, been used with
success in multivalent ligands.4,7,11,13 Determining how flexible
linkers could work in multivalent ligands, when this simple
theoretical model argues that they should not, was a key
motivation for this paper.
there are a number of well-characterized assays to use in
following binding, and there are a number of commercially
available, high-affinity arylsulfonamides to use for competition
experiments.14-17 Further, HCA is easy to overexpress in, and
purify from, Escherichia coli culture in high yield; this ease
allows the generation of HCA mutants with chemical “handles”
(i.e., reactive sites) to which to couple the ligands.18-20
An examination of crystal structures of HCA complexed with
p-substituted benzenesulfonamides containing oligo(ethylene
glycol) linkers (PDB codes 1CNY, 1CNX, and 1CNW)21
established that Lys-133 was spatially close to the terminus of
the ligand but outside of the conical cleft of the enzyme (Figure
4). Mutating this residue to Cys would generate a chemical
handle for thiol-selective coupling.18,20 HCA has an endogenous
Cys at position 206. In order to preclude side reaction at this
site, we mutated it to Ser to generate a double mutant (Cys-
206fSer, Lys-133fCys), which we refer to as HCA** in the
remainder of this paper. Krebs and Fierke demonstrated that
the C206S mutant of HCA is active,22 and Mårtensson et al.
determined that this mutant is as stable as wild-type HCA.20
(14) (a) Krishnamurthy, V. M.; Kaufman, G. K.; Urbach, A. R.; Gitlin, I.;
Gudiksen, K. L.; Weibel, D. B.; Whitesides, G. M., submitted. (b)
Christianson, D. W.; Fierke, C. A. Acc. Chem. Res. 1996, 29, 331-339.
(15) (a) Supuran, C. T.; Scozzafava, A.; Casini, A. Med. Res. ReV. 2003, 23,
146-189. (b) Supuran, C. T.; Scozzafava, A.; Conway, J. In Carbonic
Anhydrase: Its Inhibitors and ActiVators; Supuran, C. T., Scozzafava, A.,
Conway, J., Eds.; CRC Press: Boca Raton, FL, 2004; Vol. 1, pp 67-147.
(16) Chen, R. F.; Kernohan, J. C. J. Biol. Chem. 1967, 242, 5813-5823.
(17) Kernohan, J. C. Biochem. J. 1970, 120, 26P.
Experimental Design. We selected the combination of
human carbonic anhydrase II (HCA, EC 4.2.1.1) and p-
substituted benzenesulfonamides as our model system, because
it is the simplest one that we know for studying protein-ligand
interactions: the conserved mode of binding of sulfonamides
to HCA has been well-established by X-ray crystallography,
(18) Burton, R. E.; Hunt, J. A.; Fierke, C. A.; Oas, T. G. Protein Sci. 2000, 9,
776-785.
(10) Winnik, M. A. Chem. ReV. 1981, 81, 491-524.
(11) Mammen, M.; Choi, S.-K.; Whitesides, G. M. Angew. Chem., Int. Ed. 1998,
37, 2755-2794.
(19) Khalifah, R. G.; Strader, D. J.; Bryant, S. H.; Gibson, S. M. Biochemistry
1977, 16, 2241-2247.
(20) Mårtensson, L.-G.; Jonsson, B.-H.; Freskgård, P.-O.; Kihlgren, A.; Svensson,
M.; Carlsson, U. Biochemistry 1993, 32, 224-231.
(12) Mammen, M.; Shakhnovich, E. I.; Whitesides, G. M. J. Org. Chem. 1998,
63, 3168-3175.
(21) Boriack, P. A.; Christianson, D. W.; Kingery-Wood, J.; Whitesides, G. M.
J. Med. Chem. 1995, 38, 2286-2291.
(13) Choi, S.-K. Synthetic MultiValent Molecules: Concepts and Biomedical
Applications; John Wiley & Sons, Inc.: Hoboken, NJ, 2004.
(22) Krebs, J. F.; Fierke, C. A. J. Biol. Chem. 1993, 269, 948-954.
9
1314 J. AM. CHEM. SOC. VOL. 129, NO. 5, 2007